Randomized Trial Of A Short Course Of Erlotinib 150 To 300 Mg Daily Prior To Surgery For Squamous Cell Carcinomas Of The Head And Neck (Scchn) In Current, Former, And Never Smokers: Objective Responses And Clinical Outcomes.
JOURNAL OF CLINICAL ONCOLOGY(2011)
Key words
Cancer Treatment,Squamous-Cell Carcinoma
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined